Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

SAN CARLOS, Califórnia.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), uma empresa global de oncologia, anunciou hoje novos dados sobre sonrotoclax, um inibidor de BCL2 de próxima geração em investigação, demonstrando benefício clínico significativo como monoterapia e em combinação em malignidades de células B. Esses dados foram apresentados no 67º Encontro Anual & Exposição da Sociedade Americana de Hematologia (ASH) em Orlando, Flórida. As cinco apresentaç...

SAN CARLOS, Kalifornien--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), ein weltweit tätiges Onkologieunternehmen, hat heute neue Daten zu Sonrotoclax veröffentlicht, einem in der Entwicklung befindlichen BCL2-Inhibitor der nächsten Generation, der als Monotherapie und in Kombination bei B-Zell-Malignomen einen bedeutenden klinischen Nutzen zeigt. Diese Daten wurden auf dem 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Flor...

PARIS--(BUSINESS WIRE)--Havas reports the progress of transactions under its current share buyback program....

MAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions company, has achieved Level 2 certification under the US Government’s Cybersecurity Maturity Model Certification (CMMC) program – paving the way for access to sensitive defense contracts. Level 2 CMMC compliance requires defense contractors and their partners to implement, document and verify 110 rigorous cybersecurity controls through independent third-party assessment. Contenta, part of RWS’s content technology portfolio...

NEW YORK--(BUSINESS WIRE)--  8th December 2025 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 5th December 2025 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker Santander US Capital Markets LLC. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest price...

TOKYO--(BUSINESS WIRE)--Helical Fusion Co., Ltd. (Headquarters: Tokyo, Japan; “Helical Fusion”), a company developing a commercially viable Helical Stellarator power plant under its “Helix Program”, has signed a Power Purchase Agreement (PPA) with Aoki Super Co., Ltd. (Headquarters: Aichi, Japan; “Aoki Super”), a major regional supermarket chain in central Japan. This marks the first fusion-energy PPA ever signed in Japan, representing a concrete step forward in the real-world adoption of fusio...

TAIPEI, Taiwan--(BUSINESS WIRE)--CTBC Financial Holding once again stepped onto the international stage as the “Global Banking Summit 2025,” hosted by the Financial Times and The Banker, brought together global financial leaders in London from December 2 to 4. CTBC Holding President Rachael Kao joined the “CEO Keynote interview” on December 4 to share CTBC’s digital innovation, ESG strategy, and global expansion efforts—making her the only representative from Taiwan’s financial sector at this y...